Home

Prevention

Read time: 3 min

Congress highlights

Plans to prioritize brain health

At a special joint EAN/EFNA session at EAN 2019, the state secretary of the Norwegian Ministry of...

Read time: 3 min

Congress highlights

Challenges for social psychiatry in a changing world

Modern social risk factors for the development of severe psychiatric disorders, such as migration...

Depression, Schizophrenia

Read time: 4 min

Congress highlights

Lifestyle, the gut, and mental health

Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...

Read time: 5 min

Congress highlights

Ethics of psychosis prevention – Could we? Should we?

The SIRS Ethics Committee inaugurated the first of its annual symposia at SIRS 2019 to discuss the...

Read time: 3 min

Congress highlights

Biomarkers - the Future of Diagnosis in Psychiatry?

Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Encouraging immune response to AD: adjuvants, modifying the microbiome, and microglial rejuvenation

Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease....

Read time: 2 min

Long-acting injectable or oral antipsychotic for first episode psychosis?

Antipsychotic therapy improves outcomes for patients with first episode of psychosis, yet a study...

Alzheimer's Disease

Read time: 4 min

Congress highlights

What have we learned from Alzheimer’s trials?

Recent phase 3 trials in Alzheimer’s Disease teach us how to improve selection of patients so...

Read time: 4 min

Use of fidelity scales to ensure and assess high-quality first episode psychosis services

Fidelity scales ensure that services based on evidence deliver high-quality programs and outcomes,...

Depression, Alzheimer's Disease

Read time: 3 min

Global planning and local action: complementary strategies to tackle dementia

From the corridors of the WHO in Geneva to the shopping malls of Singapore, efforts are being made...

Depression, Schizophrenia

Read time: 4 min

From doubts about diagnosis to growing certainty on early intervention

‘Nowhere is the search for personalized care more important than in early psychosis. And no...

Read time: 4 min

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country